| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |